Scopa James Paul

Track

Insider profile

Performance

Overall performance
1.8
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 17% 8.2% 15.1%
Success rate 46% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -68%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Scopa James Paul's trades of Adverum Biotechnologies Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-02-09 2024-02-07
B Purchase
69,056 +45.4%
275.48
US$4,531,501 		69,056 +45.4% 275.48 US$4,531,501
2023-03-21 2023-03-17
S Sale
46,132 -14.7%
49.64
US$2,725,596 		46,132 -14.7% 49.64 US$2,725,596
2021-11-17 2021-11-15
S Sale
94,410 +45.2%
227.65
US$1,201,240 		94,410 +45.2% 227.65 US$1,201,240
2020-02-14 2020-02-14
B Purchase
10,000 +50.0%
13.75
US$137,500 		10,000 +50.0% 13.75 US$137,500
2019-05-06 2019-05-06
B Purchase
20,000 +inf%
6.71
US$134,200 		20,000 +inf% 6.71 US$134,200